Skip to content

NeoMatriX Wound Matrix

by Nextgen Biologics, Inc. 2 variants

510(k) K181330

NeoMatriX Wound Matrix is a medical device (FDA unclassified; FDA product code KGN, Wound Dressing With Animal-Derived Material(S)) made by Nextgen Biologics, Inc., cleared under FDA 510(k) K181330 on 11 Oct 2018, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK181330 Date11 Oct 2018ClearedStatusActive

Official records

From the FDA record

Received by the FDA
18 May 2018
FDA decision
11 Oct 2018 (Substantially Equivalent)
FDA review time
146 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K181330 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KGN
Device class
U
Advisory committee
Unknown
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KGN (Wound Dressing With Animal-Derived Material(S)).

Other devices from Nextgen Biologics, Inc.

See all devices from Nextgen Biologics, Inc. →